Showing 781 - 800 results of 23,250 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 59 ((nn decrease) OR (a decrease)) ))', query time: 0.92s Refine Results
  1. 781
  2. 782
  3. 783
  4. 784
  5. 785
  6. 786
  7. 787
  8. 788
  9. 789
  10. 790

    Expression of CD46, CD55 and CD59 in uremic controls (uremic patients at catheter implantation) and patients on peritoneal dialysis (PD). by Daniel Kitterer (568266)

    Published 2017
    “…RNA samples from uremic controls (n = 22), patients on PD in the L/LA-group (L/LA-group, n = 13), and patients on PD in the HA/H-group (HA/H-group, n = 11). CD46, CD55 and CD59 mRNA levels were analyzed by RT-PCR. The mean fold induction of CD46, CD55 and CD59 was normalized to the housekeeping gene 18SrRNA. …”
  11. 791
  12. 792

    Effects of Dietary Pantothenic Acid on Growth, Intestinal Function, Anti-Oxidative Status and Fatty Acids Synthesis of Juvenile Blunt Snout Bream <i>Megalobrama amblycephala</i> by Yu Qian (153240)

    Published 2015
    “…<div><p>Four groups of juvenile <i>Megalobrama amblycephala</i> were fed three times daily with six semi-purified diets containing 3.39 (PA unsupplied diet), 10.54, 19.28, 31.04, 48.38 and 59.72 mg kg<sup>-1</sup> calcium D-pantothenate. …”
  13. 793
  14. 794
  15. 795
  16. 796
  17. 797
  18. 798
  19. 799

    Advancing the science of NOWS research. by Sarah E. Maylott (14560785)

    Published 2024
    “…Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. We propose noninvasive clinical indicators of NOWS, including newborn neurobehavior, autonomic biomarkers, prenatal substance exposures, and socioeconomic environments. …”
  20. 800

    Protocol measures. by Sarah E. Maylott (14560785)

    Published 2024
    “…Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. We propose noninvasive clinical indicators of NOWS, including newborn neurobehavior, autonomic biomarkers, prenatal substance exposures, and socioeconomic environments. …”